1) Border line diabetes, [Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)]
2) As an adjunct therapy with existing hypoglycemic agents in secondary OHAs failure cases to prevent further complications.
3) In PCOS (Polycystic Ovarian Syndrome) in women leading to menstrual disorders and infertility.
Two tablets twice a day, half an-hour before meals for IGT, IFG and PCOS.
In patients on other oral hypoglycemic drugs (OHAs) one tablet twice a day may be added initially for a week.
Once satisfactory response is achieved, the dosage of OHAs may be slowly reduced and the dosage of Hyponidd to be increased to two tablets twice a day.
Information, statements and products on this website have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition.